MétaCan
Menu
Back to cohort
Record W2165097785 · doi:10.1111/apt.13126

Letter: reversibility of hepatic fibrosis and immunosuppression withdrawal in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome – author's reply

2015· letter· en· W2165097785 on OpenAlexfundno aff
Albert J. Czaja

Bibliographic record

VenueAlimentary Pharmacology & Therapeutics · 2015
Typeletter
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsnot available
FundersAlberta Innovates - Health Solutions
KeywordsMedicinePrimary biliary cirrhosisOverlap syndromeAutoimmune hepatitisAzathioprineImmunosuppressionCirrhosisLiver transplantationLiver diseaseFibrosisHepatitisDiseaseGastroenterologyImmunologyInternal medicineTransplantation

Abstract

fetched live from OpenAlex

The experience of Drs Yilmaz and Dayanan1 in patients with features of autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) is similar to that in patients with classical AIH.2, 3 Liver inflammation is probably the principal driver of fibrosis in each of these clinical syndromes.4 As Drs Yilmaz and Dayanan suggest, the suppression of inflammation can be an effective anti-fibrotic strategy even when the inflammation is accompanied by features of PBC. Other studies of PBC support these observations.5, 6 The inflammatory features associated with AIH lack disease-specificity, and their occurrence in PBC has identified patients whose outcomes may be improved by management strategies that combine corticosteroids (with or without azathioprine) and ursodeoxycholic acid.7, 8 The experience of Drs Yilmaz and Dayanan suggests that immunosuppressive therapy alone may be effective as an anti-fibrotic regimen in some patients. Furthermore, outcomes may be better than in those with classical AIH or PBC. The overlap syndromes are clinical descriptions based largely on clinical judgments, and the AIH/PBC overlap syndrome described by Drs Yilmaz and Dayanan exists within a clinical spectrum that is bounded by patients with mainly AIH and weak manifestations of PBC and by patients with mainly PBC and inflammatory features reminiscent of AIH.8 Immunosuppressive therapy has a role across the spectrum, but outcomes may differ depending on the predominant component.8 The absence of relapse after drug withdrawal suggests that PBC may have been the predominant disease in this experience. The observations of Drs Yilmaz and Dayanan indicate that immunosuppressive therapy can have anti-fibrotic effects in immune-mediated liver diseases outside the classical phenotype of AIH. Future objectives must be to characterise those patients who are likely to respond, validate non-invasive methods to monitor fibrosis, and rigorously evaluate site-specific anti-fibrotic interventions that might supplement or replace current strategies.9 The author's declarations of personal and financial interests are unchanged from those in the original article.9

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.019
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Case report · Consensus signal: none
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.022
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.019
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0010.002
Scholarly communication0.0010.003
Open science0.0030.001
Research integrity0.0220.016
Insufficient payload (model declined to judge)0.0040.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.263
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designCase report
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueAlimentary Pharmacology & TherapeuticsSame topicLiver Diseases and ImmunityFrench-language works237,207